-
MJFF Launches Funding Program to Promote Diversity, Equity and Inclusion in Parkinson’s Research
February 9, 2021
… of Parkinson’s disease (PD) is growing but remains far from complete. Unfortunately, most of this research has not … about Parkinson’s in populations that have been excluded from or underrepresented in the research. These groups …
-
Unified Parkinson's Advocacy Council
… follows the work of the Parkinson’s Action Network (PAN). From 1991 to 2016, PAN served as the unified voice of the … and loved ones on Capitol Hill and worked, with input from other Parkinson’s organizations, to positively impact …
-
MJFF Supports Health Care for America’s Veterans Exposed to Toxic Chemicals
January 21, 2022
… to toxic chemicals during service. The committee heard from activists and advocates, including The Michael J. Fox … on this topic. Service members are exposed to toxins from garbage burn pits, as well as warfare chemicals, …
-
Evaluating Patient-reported Outcome Assessment in Early Parkinson’s Disease
… explore the published literature and collect information from focus group sessions with people with PD and their care … improve identification of people with PD who might benefit from early treatment and facilitate the evaluation of …
-
Impact of TRPML1 Stimulation on Clinical Biomarkers and Synuclein Pathology
… and the processing of alpha-synuclein in neurons derived from people with GBA-associated PD. Now, we seek to further … Hypothesis: Based on prior work in neurons derived from people with PD, we predict that activation of TRPML1 …
-
Development of Small-molecule Inhibitors that Reduce the Aggregation of Tau for the Treatment of Parkinson’s Disease
… of alpha-synuclein and tau converts these proteins from a biologically functional state into toxic, fibrous … by either alpha-synuclein fibrils or tau fibrils derived from a post mortem AD brain. We will conduct these studies …